Search research articles
Contact Us
Filters
Showing results (41-50 of 52) with videos related to
Page
of 6
Sort By:
Biochemical Pharmacology
|
September 1, 1987
2',3'-Dideoxy-2'-fluoro-ara-A. An acid-stable purine nucleoside active against human immunodeficiency virus (HIV)
V E Marquez, C K Tseng, J A Kelley, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 1, 1988
Pyrimidine dideoxyribonucleosides: selectivity of penetration into cerebrospinal fluid
J M Collins, R W Klecker, J A Kelley, et al.
Cancer Research
|
April 1, 1991
Phase I bioavailability and pharmacokinetic study of hexamethylene bisacetamide (NSC 95580) administered via nasogastric tube
F T Ward, J A Kelley, J S Roth, et al.
Journal of Medicinal Chemistry
|
April 12, 1996
Lipophilic, acid-stable, adenosine deaminase-activated anti-HIV prodrugs for central nervous system delivery. 3. 6-Amino prodrugs of 2'-beta-fluoro-2',3'-dideoxyinosine
J S Driscoll, M A Siddiqui, H Ford, et al.
Journal of Medicinal Chemistry
|
June 22, 1992
Chemistry and anti-HIV properties of 2'-fluoro-2',3'-dideoxyarabinofuranosylpyrimidines
M A Siddiqui, J S Driscoll, V E Marquez, et al.
Cancer Research
|
July 1, 1985
A phase I and pharmacokinetic study of dihydro-5-azacytidine (NSC 264880)
G A Curt, J A Kelley, R L Fine, et al.
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology
|
September 1, 1995
Acute cardiotoxicity of the Anti-HIV dideoxynucleoside, F-ddA, in the rat
B A Donzanti, J A Kelley, J E Tomaszewski, et al.
Surgical Endoscopy
|
May 19, 2001
A pilot study of new approaches to teaching anatomy and pathology
A Park, R W Schwartz, D B Witzke, et al.
Journal of Medicinal Chemistry
|
March 1, 1990
Acid-stable 2'-fluoro purine dideoxynucleosides as active agents against HIV
V E Marquez, C K Tseng, H Mitsuya, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
September 1, 1987
The disposition and metabolism of 2',3'-dideoxycytidine, an in vitro inhibitor of human T-lymphotrophic virus type III infectivity, in mice and monkeys
J A Kelley, C L Litterst, J S Roth, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 52) with videos related to
Sort By:
Page
of 6
Biochemical Pharmacology
|
September 1, 1987
2',3'-Dideoxy-2'-fluoro-ara-A. An acid-stable purine nucleoside active against human immunodeficiency virus (HIV)
V E Marquez, C K Tseng, J A Kelley, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 1, 1988
Pyrimidine dideoxyribonucleosides: selectivity of penetration into cerebrospinal fluid
J M Collins, R W Klecker, J A Kelley, et al.
Cancer Research
|
April 1, 1991
Phase I bioavailability and pharmacokinetic study of hexamethylene bisacetamide (NSC 95580) administered via nasogastric tube
F T Ward, J A Kelley, J S Roth, et al.
Journal of Medicinal Chemistry
|
April 12, 1996
Lipophilic, acid-stable, adenosine deaminase-activated anti-HIV prodrugs for central nervous system delivery. 3. 6-Amino prodrugs of 2'-beta-fluoro-2',3'-dideoxyinosine
J S Driscoll, M A Siddiqui, H Ford, et al.
Journal of Medicinal Chemistry
|
June 22, 1992
Chemistry and anti-HIV properties of 2'-fluoro-2',3'-dideoxyarabinofuranosylpyrimidines
M A Siddiqui, J S Driscoll, V E Marquez, et al.
Cancer Research
|
July 1, 1985
A phase I and pharmacokinetic study of dihydro-5-azacytidine (NSC 264880)
G A Curt, J A Kelley, R L Fine, et al.
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology
|
September 1, 1995
Acute cardiotoxicity of the Anti-HIV dideoxynucleoside, F-ddA, in the rat
B A Donzanti, J A Kelley, J E Tomaszewski, et al.
Surgical Endoscopy
|
May 19, 2001
A pilot study of new approaches to teaching anatomy and pathology
A Park, R W Schwartz, D B Witzke, et al.
Journal of Medicinal Chemistry
|
March 1, 1990
Acid-stable 2'-fluoro purine dideoxynucleosides as active agents against HIV
V E Marquez, C K Tseng, H Mitsuya, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
September 1, 1987
The disposition and metabolism of 2',3'-dideoxycytidine, an in vitro inhibitor of human T-lymphotrophic virus type III infectivity, in mice and monkeys
J A Kelley, C L Litterst, J S Roth, et al.
Page
of 6